Caspase-2 deficiency drives pathogenic liver polyploidy and increases age-associated hepatocellular carcinoma in mice
Authors:
- Loretta DorstynLDLoretta Dorstyn
- Yoon LimYLYoon Lim
- Jack ScanlanJSJack Scanlan
- Dylan De BellisDBDylan De Bellis
- Michael KatschnerMKMichael Katschner
- Samantha Emery-CorbinSESamantha Emery-Corbin
- Jumana YousefJYJumana Yousef
- Laura F. DagleyLDLaura F. Dagley
- Chung H. KokChung H. Kok
- Sonia S. ShahSSSonia S. Shah
Open Access
- 2 January 2026
- journal article
- cancer
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (1) , eaeb2571
Abstract
Hepatocyte polyploidization promotes liver homeostasis by enhancing resistance to cellular stress. Caspase-2, a proapoptotic protease, restricts polyploidization by deleting polyploid and aneuploid cells. While caspase-2 protects against diet-induced hepatic injury, it also acts as a tumor suppressor by controlling genomic instability and oxidative stress. To investigate these roles, we assessed hepatic ploidy dynamics, liver damage, and age-associated tumorigenesis in caspase-2–deficient and catalytically inactive mutant mice. We found that caspase-2 loss promotes early-onset hepatocyte hyperpolyploidy, accompanied by progressive liver inflammation, fibrosis, oxidative liver damage, ferroptosis, and higher incidence of spontaneous hepatocellular carcinoma in aged animals. Proteomic profiling revealed a pathogenic polyploidy–associated signature associated with caspase-2 deficiency and increased predisposition to liver disease and malignancy. These findings establish caspase-2 enzymatic activity as a critical regulator of hepatic genome stability and preventing age-related liver cancer that strongly argue against therapeutic caspase-2 inhibition as a strategy for managing liver injury or cancer risk.Keywords
Funding Information
- National Health and Medical Research Council (APP1144500)
- National Health and Medical Research Council (APP1156601)
- National Health and Medical Research Council (APP1103006)
- National Health and Medical Research Council (APP2007739)
- National Health and Medical Research Council (APP1116936)
- National Health and Medical Research Council (APP1194141, APP1042465, APP1041760, APP1156511, APP1122227)
This publication has 59 references indexed in Scilit:
- Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in miceCell Death & Differentiation, 2013
- Metabolomic Profiling Reveals a Role for Caspase-2 in LipoapoptosisJournal of Biological Chemistry, 2013
- Caspase-2 deficiency promotes aberrant DNA-damage response and genetic instabilityCell Death & Differentiation, 2012
- Impaired antioxidant defence and accumulation of oxidative stress in caspase-2-deficient miceCell Death & Differentiation, 2012
- Characterization of Cytoplasmic Caspase-2 Activation by Induced ProximityMolecular Cell, 2009
- A tumor suppressor function for caspase-2Proceedings of the National Academy of Sciences, 2009
- BioVenn – a web application for the comparison and visualization of biological lists using area-proportional Venn diagramsBMC Genomics, 2008
- Caspase-2 deficiency enhances aging-related traits in miceMechanisms of Ageing and Development, 2007
- A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancersNature Genetics, 2006
- The biochemical mechanism of caspase-2 activationCell Death & Differentiation, 2004